1 May 2017 in Annals of Laboratory Medicine
Kyung-Hwa Shin, M.D., In-Suk Kim, M.D., Hyun Ji Lee, M.D., Hyung-Hoi Kim, M.D., Chulhun L. Chang, M.D., Young Mi Hong, M.D., Ki Tae Yoon, M.D., and Mong Cho, M.D.. Ann Lab Med 2017;37:204-12. https://doi.org/10.3343/alm.2017.37.3.204
1 November 2012 in Annals of Laboratory Medicine
Lee HJ, et al. Ann Lab Med. 2012 Nov;32(6):420-425. https://doi.org/10.3343/alm.2012.32.6.420
1 August 2023 in Journal of Clinical Laboratory Analysis
Background: Endothelial cells are vital in the transplant immune system as semiprofessional antigen‐presenting cells. Few studies have investigated the importance of anti‐endothelin subtype A receptor (ETAR) antibodies in kidney transplantation. Here, we aimed to analyze the association between anti‐angiotensin II type I receptor (AT1R) and anti‐ETAR antibodies and the association between the presence of anti‐endothelial antibodies and the risk of allograft rejection in kidney transplantation.Methods: In total, 252 patients who underwent kidney transplantation were enrolled in this study. Antibodies for human leukocyte antigens (HLAs) and non‐HLAs were analyzed immediately before transplantation. Patients were categorized based on the occurrence of antibody‐mediated rejection (AMR) or T‐cell‐mediated rejection (TCMR) by 2017 Banff classification. All p‐values were two‐tailed, and statistical significance was set at p < 0.05.Results: Patients with anti‐AT1R antibodies had a 3.49‐fold higher risk of TCMR than those without anti‐AT1R antibodies. Patients with anti‐ETAR antibodies had a 5.84‐fold higher risk of AMR than those without anti‐ETAR antibodies. The hazard ratio of AMR in patients with both HLA DSAs and anti‐ETAR antibodies, relative to patients without anti‐ETAR antibodies and HLA DSAs, was 32.85 (95% CI = 1.82–592.91).Conclusion: Our findings indicated that anti‐ETAR antibodies are associated with AMR, and patients with both anti‐ETAR antibodies and de novo HLA DSAs were at a high risk of AMR.
6 September 2018 in Laboratory Medicine
Background Hyperbilirubinemia, which is a sign of hemolytic disease of the newborn (HDN), can irreversibly damage the central nervous system. Objectives To determine the etiology of HDN in affected patients and characterize the changing pattern of bilirubin using direct antiglobulin testing (DAT). Methods We collected clinical data from newborns who underwent perinatal DAT and from their mothers, between August 2008 and July 2017. Results Among 303 neonates, 37 (12.2%) showed positive DAT results. The positive predictive values (PPVs) and negative predictive values (NPVs) based on DAT results were 75.7% and 28.9%, respectively, for starting phototherapy. Bilirubin levels increased more rapidly in the DAT-positive group, compared with the DAT-negative group. The initial bilirubin level differed significantly according to the etiology of hyperbilirubinemia. Further, neonates with anti-D showed higher delta bilirubin per day than neonates with other antibodies. Conclusion Our results may help to determine the measurement period for bilirubin according to DAT results and etiology.
1 January 2017 in Laboratory Medicine Online
Lee HJ, et al. Lab Med Online. 2017 Apr;7(2):53-58. https://doi.org/10.3343/lmo.2017.7.2.53
23 July 2020 in Laboratory Medicine
Objective: Transplantations may require massive transfusion of blood products. Therefore, blood banks need to predict, prepare, and supply the required amount of blood products. Methods: We measured the volume of transfused blood components as red blood cells, fresh frozen plasma, platelets, and cryoprecipitate in 54 and 89 patients who received heart and lung transplantation, respectively, in our hospital between January 2012 and December 2019. Results: Platelets were the most frequently transfused blood component. Transfusion volumes during heart and lung transplantation surgeries differed: red blood cells, 7.83 units vs 14.84 units; fresh frozen plasma, 2.67 units vs 12.29 units; platelets, 13.13 units vs 23.63 units; and cryoprecipitate, 1.74 units vs 2.57 units; respectively. The average transfusion volume of transplants was different each year. Conclusion: Periodic evaluation of transfusion requirements will facilitate the efficient management of blood products at the time of transplantation and help blood banks predict changes in blood requirements.